On April 5, 2019 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), reported that its first quarter 2019 financial results will be released after market close on Thursday, May 9, 2019 (Press release, Coherus Biosciences, APR 5, 2019, View Source/news-releases/news-release-details/coherus-biosciences-report-first-quarter-financial-results-may" target="_blank" title="View Source/news-releases/news-release-details/coherus-biosciences-report-first-quarter-financial-results-may" rel="nofollow">View Source [SID1234535012]). Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call to discuss financial results and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

After releasing first quarter 2019 financial results, the company will post them on the Coherus website at View Source." target="_blank" title="View Source." rel="nofollow">View Source

Conference Call Information

When: Thursday, May 9, 2019 starting at 4:30 p.m. ET
Dial-in: (844) 452-6826 (toll free) or (765) 507-2587 (International)
Conference ID: 2969536
Webcast: View Source
Please join the conference call at least 10 minutes early to register. The webcast will be archived on the Coherus website.